Transmission-Blocking Strategies in Malaria Control

Malaria control programmes increasingly target the sexual and vector stages of Plasmodium falciparum to interrupt the parasite’s life cycle and prevent onward transmission. Transmission-blocking strategies encompass chemotherapeutic agents that eliminate gametocytes in the human host, compounds that inhibit parasite development within the mosquito vector, and novel screening approaches to identify these agents. Recent advances have exploited mechanical and biochemical vulnerabilities of circulating gametocytes, developed sensitive multi-stage assays, and used high-throughput platforms to discover new chemical scaffolds. By focusing on bottleneck stages—gametogenesis, sporogonic development and sporozoite formation—these interventions aim to complement existing blood-stage treatments and insecticide-based vector control, thereby contributing to malaria elimination efforts worldwide.

Research from Nature Portfolio

Innovative mechanical screening methods have revealed orally available drugs that stiffen and eliminate transmissible gametocytes by mimicking splenic clearance. This approach identified clinically approved compounds with potent activity against stage V gametocytes and favourable safety profiles in early human trials. Complementing this, bioluminescent reporter parasites expressing NanoLuciferase throughout their life cycle have been engineered to enable highly sensitive, quantitative assays across asexual, sexual, mosquito and liver stages. This tool has streamlined multi-stage drug evaluation and facilitated the discovery of compounds active against gametocytes. Building on these techniques, a comprehensive high-throughput screen of diverse chemical libraries targeted gametogenesis and sporogony, yielding novel molecules with male-specific, female-specific and dual-action transmission-blocking properties, including a lead scaffold with sub-micromolar activity and demonstrated in vivo efficacy.

Transmission-Blocking Strategies in Malaria Control publication trend

The graph below shows the total number of articles in transmission-blocking strategies in malaria control across all publications each year (not limited to Nature Index journals).

Technical terms

Gametocyte: The sexual form of Plasmodium falciparum circulating in human blood that is transmissible to mosquitoes.

Sporogony: The developmental phase of the parasite within the mosquito vector leading to formation of sporozoites.

High-throughput screening: A method for rapidly testing large libraries of compounds for biological activity using automated assays.

Spleen-mimetic screening: A mechanical filtration technique that replicates splenic clearance of less deformable infected red blood cells to identify drugs that stiffen gametocytes.

NanoLuciferase reporter: A bioluminescent enzyme genetically expressed by parasites to enable sensitive quantification of parasite stages in drug assays.

References

1. Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening. Nature Communications (2023).
2. A versatile Plasmodium falciparum reporter line expressing NanoLuc enables highly sensitive multi-stage drug assays. Communications Biology (2023).
3. A high throughput screen for next-generation leads targeting malaria parasite transmission. Nature Communications (2018).
4. Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development. Pharmaceuticals (2024).
5. Machine learning-based phenotypic imaging to characterise the targetable biology of Plasmodium falciparum male gametocytes for the development of transmission-blocking antimalarials. PLOS Pathogens (2023).